Stockscreener 앱 받기
19.01
1.66%
0.31
시간 외 거래:
19.01
전일 마감가:
$18.70
열려 있는:
$18.71
하루 거래량:
112.49K
Relative Volume:
0.93
시가총액:
$350.98M
수익:
$925.94M
순이익/손실:
$9.15M
주가수익비율:
39.98
EPS:
0.4755
순현금흐름:
$8.53M
1주 성능:
+5.32%
1개월 성능:
+0.26%
6개월 성능:
-5.23%
1년 성능:
-36.23%
1일 변동 폭
$18.38
$19.29
1주일 범위
$17.36
$19.29
52주 변동 폭
$16.60
$35.55
Usana Health Sciences Inc Stock (USNA) Company Profile
명칭
Usana Health Sciences Inc
전화
(801) 954-7100
주소
3838 WEST PARKWAY BLVD., SALT LAKE CITY, UT
Compare USNA vs KHC, GIS, HRL, MKC, JBS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
USNA
Usana Health Sciences Inc
|
19.01 | 345.26M | 925.94M | 9.15M | 8.53M | 0.4755 |
KHC
Kraft Heinz Co
|
23.43 | 27.69B | 24.99B | -5.76B | 3.95B | -4.863 |
GIS
General Mills Inc
|
33.72 | 17.69B | 18.37B | 2.22B | 1.65B | 4.0676 |
HRL
Hormel Foods Corp
|
23.98 | 13.01B | 12.22B | 466.64M | 692.94M | 0.8477 |
MKC
Mccormick Co Inc
|
48.63 | 12.80B | 7.11B | 1.65B | 680.40M | 6.1005 |
JBS
Jbs Nv
|
11.85 | 12.44B | 88.25B | 1.91B | -681.64M | 1.6761 |
Usana Health Sciences Inc Stock (USNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-06-23 | 개시 | Sidoti | Buy |
| 2022-07-07 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2022-04-14 | 개시 | DA Davidson | Neutral |
| 2020-12-17 | 개시 | ROTH Capital | Buy |
| 2019-08-22 | 개시 | Jefferies | Hold |
| 2019-04-16 | 개시 | Tigress Financial | Buy |
| 2018-10-25 | 업그레이드 | Sidoti | Neutral → Buy |
| 2018-10-24 | 업그레이드 | Pivotal Research Group | Hold → Buy |
| 2018-04-23 | 다운그레이드 | Pivotal Research Group | Buy → Hold |
| 2018-02-07 | 재확인 | Pivotal Research Group | Buy |
| 2018-01-24 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2017-10-25 | 재확인 | Pivotal Research Group | Buy |
| 2017-07-26 | 재확인 | Pivotal Research Group | Buy |
| 2017-05-03 | 업그레이드 | Pivotal Research Group | Hold → Buy |
| 2017-05-01 | 다운그레이드 | Pivotal Research Group | Buy → Hold |
| 2017-02-08 | 재확인 | Pivotal Research Group | Buy |
| 2016-07-28 | 재확인 | DA Davidson | Neutral |
| 2016-02-10 | 다운그레이드 | DA Davidson | Buy → Neutral |
| 2015-10-16 | 업그레이드 | Sidoti | Neutral → Buy |
| 2015-09-16 | 업그레이드 | DA Davidson | Neutral → Buy |
| 2015-08-06 | 다운그레이드 | DA Davidson | Buy → Neutral |
| 2015-08-05 | 업그레이드 | Pivotal Research Group | Hold → Buy |
| 2015-06-26 | 개시 | DA Davidson | Buy |
모두보기
Usana Health Sciences Inc 주식(USNA)의 최신 뉴스
Insider Sell: Paul Jones Sells 5,561 Shares of Usana Health Scie - GuruFocus
Usana chief people officer Paul Jones sells $102,878 in stock - Investing.com India
Usana chief people officer Paul Jones sells $102,878 in stock By Investing.com - Investing.com Canada
USANA (USNA) chief people officer sells 5,561 shares, exits stake - Stock Titan
Paul A. Jones sells 6,813 USNA shares; broker Morgan Stanley (USNA) - Stock Titan
USANA Honored at Canadian Beauty Awards - directsellingnews.com
USANA's Celavive Contouring Face & Neck Crème Named Among Canada's Top Skincare Products - marketscreener.com
Earnings call transcript: USANA Health Sciences beats Q1 2026 expectations - Investing.com
USANA Earns Dual Best of State Honors for Product Innovation and Development – Company Announcement - Financial Times
Usana director John Fleming sells $43,928 in company stock By Investing.com - Investing.com Australia
Usana director John Fleming sells $43,928 in company stock - Investing.com
Director at USANA (NYSE: USNA) sells 2,450 shares at $17.93 - Stock Titan
Each USANA CEO's wellness book funds 40 meals for hungry kids - Stock Titan
Insider Sell: John Fleming Sells 2,450 Shares of Usana Health Sc - GuruFocus
USANA Health Sciences Chief People Officer Paul Jones Sells 55% Of Holding - simplywall.st
Usana Health Sciences CPO Paul Jones sells $129,106 of stock By Investing.com - Investing.com South Africa
Usana Health Sciences CPO Paul Jones sells $129,106 of stock - Investing.com
USANA (USNA) Chief People Officer sells 6,813 shares, retains 5,561 - Stock Titan
USANA top MLM earners 2026 and their growth impact in the direct selling industry - Epixel MLM Software
USNA (NYSE) Form 144: Restricted stock sale notices including 1,775 shares - Stock Titan
Usana Health Sciences CFO sells $100,513 in company stock - Investing.com
Usana Health Sciences CFO sells $100,513 in company stock By Investing.com - Investing.com Canada
USANA (NYSE: USNA) CFO sells 5,360 Common Stock shares in market trade - Stock Titan
USNA (NYSE) broker files Form 144 listing planned restricted-stock dispositions - Stock Titan
Usana Health Sciences director Gilbert A. Fuller sells $19,728 in stock - Investing.com UK
USANA (NYSE: USNA) director Fuller sells 1,057 common shares - Stock Titan
USANA Health Sciences (USNA) Climbs 0.97% as Stock Approaches Key Resistance ZoneTake Profit Levels - The Legal Advocate
Should Value Investors Buy USANA Health Sciences (USNA) Stock? - Yahoo Finance
USANA Health Sciences Faces Evaluation Shift Amid Ongoing Financial Challenges - MarketsMojo
Precision Trading with Usana Health Sciences Inc. (USNA) Risk Zones - Stock Traders Daily
Usana Health Sciences shareholders elect board and approve auditor at annual meeting By Investing.com - Investing.com India
Q1 Personal Care Stocks Review: Inter Parfums and USANA Health SciencesNews and Statistics - IndexBox
Usana Health Sciences shareholders elect board and approve auditor at annual meeting - Investing.com
[8-K] USANA HEALTH SCIENCES INC Reports Material Event - Stock Titan
USNA Stock Price, Quote & Chart | USANA HEALTH SCIENCES INC (NYSE:USNA) - ChartMill
USANA projects $925M-$1B 2026 net sales as omnichannel mix targets over 20% - MSN
5 Revealing Analyst Questions From USANA’s Q1 Earnings Call - Yahoo Finance
USANA Health Sciences Experiences Valuation Adjustment Amidst Market Challenges and Performance Metrics - Markets Mojo
USANA (NYSE: USNA) Q1 2026 shows flat sales and lower profit - Stock Titan
USANA (USNA) Q1 2026 Earnings Call Transcript - AOL.com
USANA Health (USNA) upgraded to buy: What does it mean for the stock? - MSN
Director at USANA (NYSE: USNA) granted 6,527 restricted stock units - Stock Titan
USANA (USNA) director J Scott Nixon awarded 6,527 restricted stock units - Stock Titan
Usana Health Sciences Inc (USNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.92%
자본화:
|
볼륨(24시간):